Evonik Opens Expanded Production Facilities in Japan

Will produce specialty silica product lines

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Evonik has opened its newly expanded facilities in Ako, Japan, which will produce its SIPERNAT and CARPLEX lines of specialty silicas. The investment adds a 50% increase Japanese production capacity for specialty silicas, which the specialty chemicals company manufactures through DSL. Japan Co., Ltd. (DSL). Evonik has a 51% stake in DSL, a joint venture with the Shionogi & Co., Ltd. in Japan. Applications for SIPERNAT and CARPLEX are used as drug carriers in pharmaceuticals, and as flow aid...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters